COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 1743: Articles 17421-17430  | Next

Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine
Velasco, M., Galan, M. I., Casas, M. L., Perez-Fernandez, E., Gonzalez-Pinyeiro, B., Castilla, V., Guijarro, C.
10.1101/2021.03.08.21253065 — Posted: 2021-03-10
Anti-SARS-CoV-2 Serology persistence over time in COVID-19 Convalescent Plasma Donors.
De Giorgi, V., West, K. A., Henning, A. N., Chen, L., Holbrook, M. R., Gross, R., Liang, J., Postnikova, E., Trenbeath, J., Pogue, S., Scinto, T., Alter, H. J., Cantilena, C. C.
10.1101/2021.03.08.21253093 — Posted: 2021-03-10
Efficacy of remdesivir in Japanese patients hospitalised with COVID-19: A large observational study using the COVID-19 Registry Japan
Tsuzuki, S., Hayakawa, K., Matsunaga, N., Terada, M., Suzuki, S., Ohtsu, H., Asai, Y., Kitajima, K., Saito, S., Uemura, Y., Shibata, T., Kondo, M., Izumi, K., Hojo, M., Mizoue, T., Yokota, K., Nakamura-Uchiyama, F., Saito, F., Sugiura, W., Ohmagari, N.
10.1101/2021.03.09.21253183 — Posted: 2021-03-10
COVID-19 is associated with multiple sclerosis exacerbations that are prevented by disease modifying therapies
Garjani, A., Middleton, R. M., Hunter, R., Tuite-Dalton, K. A., Coles, A., Dobson, R., Duddy, M., Hughes, S., Pearson, O. R., Rog, D., Tallantyre, E. C., das Nair, R., Nicholas, R., Evangelou, N.
10.1101/2021.03.08.21253141 — Posted: 2021-03-10
A High Rate of COVID-19 Vaccine Hesitancy Among Arabs: Results of a Large-scale Survey
Qunaibi, E. A., Helmy, M., Basheti, I., Sultan, I.
10.1101/2021.03.09.21252764 — Posted: 2021-03-10 Discussion: Onsite
Increased mortality among individuals hospitalised with COVID-19 during the second wave in South Africa
Jassat, W., Mudara, C., Ozougwu, L., Tempia, S., Blumberg, L., Davies, M.-A., Pillay, Y., Carter, T., Morewane, R., Wolmarans, M., von Gottberg, A., Bhiman, J. N., Walaza, S., Cohen, C.
10.1101/2021.03.09.21253184 — Posted: 2021-03-10
Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics: A cross-sectional study
Hirschtick, J. L., Titus, A. R., Slocum, E., Power, L. E., Hirschtick, R. E., Elliott, M. R., McKane, P., Fleischer, N. L.
10.1101/2021.03.08.21252905 — Posted: 2021-03-10 Discussion: Onsite
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Estcourt, L., Peto, L., Emberson, J. R., Staplin, N., Spata, E., Pessoa-Amorim, G., Campbell, M., Roddick, A., Brunskill, N. E., George, T., Zehnder, D., Tiberi, S., Aung, N. N., Uriel, A., Widdrington, J., Koshy, G., Brown, T., Scott, S., Baillie, J. K., Buch, M. H., Chappell, L. C., Day, J. N., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Lim, W. S., Montgomery, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Roberts, D., Haynes, R., Landray, M. J.
10.1101/2021.03.09.21252736 — Posted: 2021-03-10 Discussion: Offsite
Plasma ACE2 levels predict outcome of COVID-19 in hospitalized patients
Kragstrup, T. W., Singh, H. S., Grundberg, I., Nielsen, A. L. L., Rivellese, F., Mehta, A., Goldberg, M. B., Filbin, M., Qvist, P., Bibby, B. M.
10.1101/2021.03.08.21252819 — Posted: 2021-03-10 Discussion: Onsite
Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection
Ioannou, G., O'Hare, A. M., Berry, K., Fan, V. S., Crothers, K., Eastment, M. C., Locke, E., Green, P., Shah, J. A., Dominitz, J.
10.1101/2021.03.08.21253090 — Posted: 2021-03-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).